Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
866
Sort by:
Hepatitis B Vaccine Market - Forecast from 2026 to 2031
US$ 3,950.00
The Hepatitis B vaccine market, with a 5.49% CAGR, is expected to grow to USD 10.767 billion in 2031 from USD 7.813 billion in 2025. The hepatitis B vaccine market is a critical and mature segment wit...
January 2026
149 pages
Encephalitis Vaccines Market 2026
US$ 2,999.00
The Encephalitis Vaccines Market was valued at in and is anticipated to reach by , at a CAGR of 0.054 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
December 2025
217 pages
Shigella Vaccines Pipeline Market 2026
US$ 2,999.00
The Shigella Vaccines Pipeline Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
December 2025
210 pages
Polio Vaccine Market - 2024-2033
US$ 2,999.00
The Polio Vaccine Market was valued at US$ 804.77 million in 2024 and is anticipated to reach US$ 1,249.17 million by 2033, at a CAGR of 0.056 from 2026 to 2032. The report delivers in-depth insights...
December 2025
220 pages
Microneedle Flu Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Solid Microneedle, Hollow Microneedle), By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine), By Region, By Competition, 2020-2030F
US$ 4,500.00
The Global Microneedle Flu Vaccine Market, valued at USD 1.18 Billion in 2024, is projected to experience a CAGR of 5.96% to reach USD 1.67 Billion by 2030. The global microneedle flu vaccine is an in...
December 2025
186 pages
Rabies Vaccine Market By Product Type (Chick Embryo Cells Rabies Vaccine, Vero Cell Rabies Vaccine, Human Diploid Cell Vaccine, Human Rabies Immune Globulin (HRIG), Others), By Prophylaxis Type (Pre-exposure prophylaxis, Post-exposure prophylaxis), By Application (Human, Animal), By End User (Hospitals, Veterinary clinics, Others): Global Opportunity Analysis and Industry Forecast, 2025-2034
US$ 2,655.00
The rabies vaccine market was valued at $1,319.90 million in 2024 and is estimated to reach $2,041.90 million by 2034, exhibiting a CAGR of 4.5% from 2025 to 2034. Rabies remains a significant public...
December 2025
319 pages
23-Valent Pneumococcal Polysaccharide Vaccine Market 2026
US$ 2,999.00
The 23-Valent Pneumococcal Polysaccharide Vaccine Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dyn...
November 2025
200 pages
Age Related Vaccine Adjuvant Market 2026
US$ 2,999.00
The Age Related Vaccine Adjuvant Market was valued at in and is anticipated to reach by , at a CAGR of 0.106 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
243 pages
Anthrax Vaccines Market 20262031
US$ 2,999.00
The Anthrax Vaccines Market was valued at in and is anticipated to reach by 2031, at a CAGR of 0.074 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
November 2025
218 pages
Biodefense Market 2026
US$ 2,999.00
The Biodefense Market was valued at in and is anticipated to reach by , at a CAGR of 0.057 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
November 2025
243 pages
Combination Vaccines Market 2026
US$ 2,999.00
The Combination Vaccines Market was valued at in and is anticipated to reach by , at a CAGR of 0.11 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
220 pages
Dendritic Cell Cancer Vaccines Market 2026
US$ 2,999.00
The Dendritic Cell Cancer Vaccines Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
217 pages
Dengue Vaccine Market 20262031
US$ 2,999.00
The Dengue Vaccine Market was valued at in and is anticipated to reach by 2031, at a CAGR of 0.104 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
218 pages
H1N1 (swine flu) Vaccination Market 2026
US$ 2,999.00
The H1N1 (swine flu) Vaccination Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
200 pages
Human Anti-rabies Vaccine Market - 2023-2031
US$ 2,999.00
The Human Anti-rabies Vaccine Market was valued at US$ 1103.5 million in 2023 and is anticipated to reach US$ 1541.4 million by 2031, at a CAGR of 0.057 from 2026 to 2032. The report delivers in-depth...
November 2025
210 pages
Malaria Vaccines Market 2026
US$ 2,999.00
The Malaria Vaccines Market was valued at in and is anticipated to reach by , at a CAGR of 0.3185 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
218 pages
Meningitis Vaccines Market 2026
US$ 2,999.00
The Meningitis Vaccines Market was valued at in and is anticipated to reach by , at a CAGR of 0.096 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
219 pages
Pertussis Vaccine Market 2026
US$ 2,999.00
The Pertussis Vaccine Market was valued at in and is anticipated to reach by , at a CAGR of 0.096 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
219 pages
Therapeutic Vaccine Market 2026
US$ 2,999.00
The Therapeutic Vaccine Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
218 pages
Varicella Attenuated Live Vaccine Market 2026
US$ 2,999.00
The Varicella Attenuated Live Vaccine Market was valued at in and is anticipated to reach by , at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
November 2025
220 pages
Viral Vector Vaccines Market 20262029
US$ 2,999.00
The Viral Vector Vaccines Market was valued at in and is anticipated to reach by 2029, at a CAGR of 0.14 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
November 2025
210 pages
